Literature DB >> 14520627

Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.

Kamyar Kalantar-Zadeh1, Charles J McAllister, Robert S Lehn, Grace H Lee, Allen R Nissenson, Joel D Kopple.   

Abstract

BACKGROUND: Elements of malnutrition-inflammation complex syndrome (MICS) may blunt the responsiveness of anemia of end-stage renal disease (ESRD) to recombinant human erythropoietin (EPO).
METHODS: The authors examined cross-sectional associations between the required dose of EPO within a 13-week interval as prescribed by practicing nephrologists who were blind to the study and several laboratory values known to be related to nutrition and/or inflammation, as well as the malnutrition-inflammation score (MIS), which is a fully quantitative assessment tool based on the subjective global assessment of nutrition.
RESULTS: A total of 339 maintenance hemodialysis (MHD) outpatients, including 181 men, who were aged 54.7 +/- 14.5 years (mean +/- SD), who had undergone dialysis for 36.3 +/- 33.2 months, were selected randomly from 7 DaVita dialysis units in Los Angeles South/East Bay area. The average weekly dose of administered recombinant human EPO within a 13-week interval was 217 +/- 187 U/kg. Patients were receiving intravenous iron supplementation (iron gluconate or dextran) averaging 39.5 +/- 47.5 mg/wk. The MIS and serum concentrations of high-sensitivity C-reactive protein, interleukin 6 (IL-6), tumor necrosis factor-alpha, and lactate dehydrogenase had positive correlation with required EPO dose and EPO responsiveness index (EPO divided by hemoglobin), whereas serum total iron binding capacity (TIBC), prealbumin and total cholesterol, as well as blood lymphocyte count had statistically significant but negative correlations with indices of refractory anemia. Most correlations remained significant even after multivariate adjustment for case-mix and anemia factors and other relevant covariates. Similar associations were noticed across EPO per body weight tertiles via analysis of variance and after estimating odds ratio for higher versus lower tertile via logistic regression after same case-mix adjustment.
CONCLUSION: The existence of elements of MICS as indicated by a high MIS and increased levels of proinflammatory cytokines such as IL-6 as well as decreased nutritional values such as low serum concentrations of total cholesterol, prealbumin, and TIBC correlates with EPO hyporesponsiveness in MHD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14520627     DOI: 10.1016/s0272-6386(03)00915-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  70 in total

1.  Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients.

Authors:  Uyen Duong; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Joshua J Zaritsky; Isaac Teitelbaum; Csaba P Kovesdy; Rajnish Mehrotra
Journal:  Am J Nephrol       Date:  2012-01-26       Impact factor: 3.754

2.  Determinants of hemoglobin variability in stable peritoneal dialysis patients.

Authors:  Hakki Arikan; Ebru Asicioglu; Arzu Velioglu; Serdar Nalcaci; Gurdal Birdal; Derya Guler; Mehmet Koc; Serhan Tuglular; Cetin Ozener
Journal:  Int Urol Nephrol       Date:  2014-04-01       Impact factor: 2.370

Review 3.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

4.  Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia.

Authors:  Takashi Maruyama; Terumi Higuchi; Toshio Yamazaki; Erina Okawa; Hideyuki Ando; Osamu Oikawa; Atsushi Inoshita; Kazuyoshi Okada; Masanori Abe
Journal:  Cardiorenal Med       Date:  2017-04-20       Impact factor: 2.041

5.  Effectiveness of oral iron to manage anemia in long-term hemodialysis patients with the use of ultrapure dialysate.

Authors:  Akiyasu Tsuchida; Bishnuhari Paudyal; Pramila Paudyal; Yoshitaka Ishii; Keiju Hiromura; Yoshihisa Nojima; Minoru Komai
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

6.  Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Deborah L Regidor; Csaba P Kovesdy; David Van Wyck; Suphamai Bunnapradist; Tamara B Horwich; Gregg C Fonarow
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

7.  Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients.

Authors:  Ronney Shantouf; Matthew J Budoff; Naser Ahmadi; Jima Tiano; Ferdinand Flores; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2007-11-09       Impact factor: 3.754

8.  Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study.

Authors:  Mehdi Rambod; Rachelle Bross; Jennifer Zitterkoph; Deborah Benner; Juhi Pithia; Sara Colman; Csaba P Kovesdy; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2008-12-13       Impact factor: 8.860

9.  Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

Authors:  Deborah L Regidor; Csaba P Kovesdy; Rajnish Mehrotra; Mehdi Rambod; Jennie Jing; Charles J McAllister; David Van Wyck; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 10.121

10.  Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness.

Authors:  Angel L M de Francisco; Peter Stenvinkel; Sophie Vaulont
Journal:  NDT Plus       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.